Literature DB >> 29327813

Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes.

Bruno Alvarez1, Carolina Barra1, Morten Nielsen1,2, Massimo Andreatta1.   

Abstract

Recent advances in proteomics and mass-spectrometry have widely expanded the detectable peptide repertoire presented by major histocompatibility complex (MHC) molecules on the cell surface, collectively known as the immunopeptidome. Finely characterizing the immunopeptidome brings about important basic insights into the mechanisms of antigen presentation, but can also reveal promising targets for vaccine development and cancer immunotherapy. This report describes a number of practical and efficient approaches to analyze immunopeptidomics data, discussing the identification of meaningful sequence motifs in various scenarios and considering current limitations. Guidelines are provided for the filtering of false hits and contaminants, and to address the problem of motif deconvolution in cell lines expressing multiple MHC alleles, both for the MHC class I and class II systems. Finally, it is demonstrated how machine learning can be readily employed by non-expert users to generate accurate prediction models directly from mass-spectrometry eluted ligand data sets.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  GibbsCluster; MHC; mass spectrometry; prediction models; sequence motifs

Mesh:

Substances:

Year:  2018        PMID: 29327813      PMCID: PMC6279437          DOI: 10.1002/pmic.201700252

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  45 in total

1.  Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.

Authors:  Thomas Delong; Timothy A Wiles; Rocky L Baker; Brenda Bradley; Gene Barbour; Richard Reisdorph; Michael Armstrong; Roger L Powell; Nichole Reisdorph; Nitesh Kumar; Colleen M Elso; Megan DeNicola; Rita Bottino; Alvin C Powers; David M Harlan; Sally C Kent; Stuart I Mannering; Kathryn Haskins
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

2.  MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.

Authors:  J Patrick Murphy; Prathyusha Konda; Daniel J Kowalewski; Heiko Schuster; Derek Clements; Youra Kim; Alejandro M Cohen; Tanveer Sharif; Morten Nielsen; Stefan Stevanovic; Patrick W Lee; Shashi Gujar
Journal:  J Proteome Res       Date:  2017-03-21       Impact factor: 4.466

3.  Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.

Authors:  Massimo Andreatta; Vanessa I Jurtz; Thomas Kaever; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

4.  Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach.

Authors:  Massimo Andreatta; Ole Lund; Morten Nielsen
Journal:  Bioinformatics       Date:  2012-10-24       Impact factor: 6.937

Review 5.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  A large fraction of HLA class I ligands are proteasome-generated spliced peptides.

Authors:  Juliane Liepe; Fabio Marino; John Sidney; Anita Jeko; Daniel E Bunting; Alessandro Sette; Peter M Kloetzel; Michael P H Stumpf; Albert J R Heck; Michele Mishto
Journal:  Science       Date:  2016-10-20       Impact factor: 47.728

7.  Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.

Authors:  Michal Bassani-Sternberg; Eva Bräunlein; Richard Klar; Thomas Engleitner; Pavel Sinitcyn; Stefan Audehm; Melanie Straub; Julia Weber; Julia Slotta-Huspenina; Katja Specht; Marc E Martignoni; Angelika Werner; Rüdiger Hein; Dirk H Busch; Christian Peschel; Roland Rad; Jürgen Cox; Matthias Mann; Angela M Krackhardt
Journal:  Nat Commun       Date:  2016-11-21       Impact factor: 14.919

8.  High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

Authors:  Danilo Ritz; Andreas Gloger; Benjamin Weide; Claus Garbe; Dario Neri; Tim Fugmann
Journal:  Proteomics       Date:  2016-05       Impact factor: 3.984

9.  The immune epitope database (IEDB) 3.0.

Authors:  Randi Vita; James A Overton; Jason A Greenbaum; Julia Ponomarenko; Jason D Clark; Jason R Cantrell; Daniel K Wheeler; Joseph L Gabbard; Deborah Hix; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

10.  Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity.

Authors:  Geert P M Mommen; Fabio Marino; Hugo D Meiring; Martien C M Poelen; Jacqueline A M van Gaans-van den Brink; Shabaz Mohammed; Albert J R Heck; Cécile A C M van Els
Journal:  Mol Cell Proteomics       Date:  2016-01-13       Impact factor: 5.911

View more
  18 in total

Review 1.  The role of proteomics in the age of immunotherapies.

Authors:  Sarah A Hayes; Stephen Clarke; Nick Pavlakis; Viive M Howell
Journal:  Mamm Genome       Date:  2018-07-25       Impact factor: 2.957

2.  A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction.

Authors:  Shutao Mei; Fuyi Li; André Leier; Tatiana T Marquez-Lago; Kailin Giam; Nathan P Croft; Tatsuya Akutsu; A Ian Smith; Jian Li; Jamie Rossjohn; Anthony W Purcell; Jiangning Song
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

3.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

4.  Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism.

Authors:  Xiaohui Wei; Song Wang; Zhuolin Li; Zibin Li; Zehui Qu; Suqiu Wang; Baohua Zou; Ruiying Liang; Chun Xia; Nianzhi Zhang
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.

Authors:  Birkir Reynisson; Bruno Alvarez; Sinu Paul; Bjoern Peters; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

Review 6.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

7.  ImmunomeBrowser: a tool to aggregate and visualize complex and heterogeneous epitopes in reference proteins.

Authors:  Sandeep Kumar Dhanda; Randi Vita; Brendan Ha; Alba Grifoni; Bjoern Peters; Alessandro Sette
Journal:  Bioinformatics       Date:  2018-11-15       Impact factor: 6.937

8.  A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients.

Authors:  Jan Koster; Ronald H A Plasterk
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

9.  Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction.

Authors:  Carolina Barra; Chloe Ackaert; Birkir Reynisson; Jana Schockaert; Leon Eyrich Jessen; Mark Watson; Anne Jang; Simon Comtois-Marotte; Jean-Philippe Goulet; Sofie Pattijn; Eustache Paramithiotis; Morten Nielsen
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

10.  Footprints of antigen processing boost MHC class II natural ligand predictions.

Authors:  Carolina Barra; Bruno Alvarez; Sinu Paul; Alessandro Sette; Bjoern Peters; Massimo Andreatta; Søren Buus; Morten Nielsen
Journal:  Genome Med       Date:  2018-11-16       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.